Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.45 USD | +1.37% |
|
+2.39% | -17.67% |
Jul. 03 | First Foundation plunges as 'unexpected' fund raise puts real estate loans in focus | RE |
Jul. 03 | Global markets live: Eli Lilly, Apple, Walmart, Shell, Rio Tinto... | ![]() |
Strengths
- The company's share price in relation to its net book value makes it look relatively cheap.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The opinion of analysts covering the stock has improved over the past four months.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's earnings growth outlook lacks momentum and is a weakness.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Banks
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-17.67% | 3.53B | - | ||
+20.39% | 588B | C+ | ||
+20.02% | 316B | C+ | ||
+23.04% | 268B | C+ | ||
+21.13% | 208B | C | ||
+15.27% | 175B | B- | ||
+27.52% | 175B | B- | ||
+6.00% | 158B | C+ | ||
-3.58% | 150B | B- | ||
+10.60% | 154B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- NYCB Stock
- NYCB.PRA Stock
- Ratings New York Community Bancorp, Inc.